IL-17F deficiency inhibits small intestinal tumorigenesis in ApcMin/+ mice

Wook-Jin Chae1, Alfred L M Bothwell

  • 1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Insights

Interleukin-17F (IL-17F) promotes intestinal tumor development. Removing IL-17F significantly reduced spontaneous intestinal tumors in mice, highlighting its role in gut tumorigenesis.

Area of Science:

  • Immunology
  • Gastroenterology
  • Oncology

Background:

  • Interleukin-17 (IL-17) is crucial for gut homeostasis.
  • The specific role of IL-17F in intestinal tumorigenesis remains unclear.

Purpose of the Study:

  • To investigate the function of IL-17F in spontaneous intestinal tumorigenesis.
  • To elucidate the molecular mechanisms underlying IL-17F's involvement in tumor development.

Main Methods:

  • Utilized Apc(Min/+) mice lacking IL-17F to study spontaneous intestinal tumor formation.
  • Analyzed gene expression (IL-1β, Cox-2, IL-17RC) and immune cell infiltration in tumor tissues and the lamina propria.
  • Assessed systemic effects by monitoring splenomegaly and thymic atrophy.

Main Results:

  • Ablation of IL-17F significantly inhibited spontaneous intestinal tumorigenesis in Apc(Min/+) mice.
  • IL-17F deficiency led to decreased expression of IL-1β, Cox-2, and IL-17RC in tumors.
  • Reduced immune cell infiltration in the lamina propria was observed in IL-17F deficient mice, suggesting a local effect.
  • IL-17A expression from CD4 T cells remained unchanged, indicating IL-17F's distinct role.

Conclusions:

  • IL-17F plays a critical, pro-inflammatory role in the development of spontaneous intestinal tumors in Apc(Min/+) mice.
  • The findings suggest IL-17F is essential for intestinal tumorigenesis, acting locally and in conjunction with IL-17A.